HealthInvest Partners AB - Q3 2016 holdings

$134 Million is the total value of HealthInvest Partners AB's 15 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 50.0% .

 Value Shares↓ Weighting
CAH BuyCARDINAL HEALTH INC$17,933,000
+43.7%
230,800
+44.2%
13.34%
+133.2%
ABC BuyAMERISOURCEBERGEN CORP$17,125,000
+34.9%
212,000
+32.5%
12.74%
+119.0%
ANTM BuyANTHEM INC$17,030,000
+38.1%
135,900
+44.7%
12.67%
+124.1%
INCR SellINC RESH HLDGS INCcl a$9,936,000
-9.0%
222,875
-22.1%
7.39%
+47.7%
CRL SellCHARLES RIV LABS INTL INC$9,885,000
-19.9%
118,612
-20.7%
7.36%
+30.1%
GNCIQ SellGNC HLDGS INC$9,862,000
-40.5%
482,955
-29.2%
7.34%
-3.4%
MRK SellMERCK & CO INC$9,805,000
-24.1%
157,100
-29.9%
7.30%
+23.2%
ANIK SellANIKA THERAPEUTICS INC$9,737,000
-56.0%
203,493
-50.7%
7.25%
-28.6%
GTS SellTRIPLE-S MGMT CORPcl b$9,428,000
-27.6%
429,904
-19.3%
7.02%
+17.5%
TARO SellTARO PHARMACEUTICAL INDS LTD$9,416,000
-25.0%
85,205
-1.2%
7.01%
+21.8%
SUPN SellSUPERNUS PHARMACEUTICALS INC$9,386,000
-29.9%
379,533
-42.3%
6.98%
+13.7%
PGNX NewPROGENICS PHARMACEUTICALS IN$1,772,000280,000
+100.0%
1.32%
ICCC  IMMUCELL CORP$1,301,000
+12.1%
168,3230.0%0.97%
+82.0%
BIL NewSPDR SERIES TRUSTbrclys 1-3mt etf$915,00020,000
+100.0%
0.68%
SHY NewISHARES TR1-3 yr tr bd etf$850,00010,000
+100.0%
0.63%
OSUR ExitORASURE TECHNOLOGIES INC$0-475,771
-100.0%
-1.29%
INSYQ ExitINSYS THERAPEUTICS INC NEW$0-788,175
-100.0%
-4.68%
CXRXF ExitCONCORDIA INTL CORP$0-543,000
-100.0%
-5.36%
LPNT ExitLIFEPOINT HEALTH INC$0-185,851
-100.0%
-5.57%
FEIC ExitFEI CO$0-118,609
-100.0%
-5.81%
AMAG ExitAMAG PHARMACEUTICALS INC$0-671,585
-100.0%
-7.37%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-10-24
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARLES RIV LABS INTL INC17Q4 201712.8%
GILEAD SCIENCES INC16Q4 202214.5%
CARDINAL HEALTH INC15Q4 202214.8%
IMMUCELL CORP15Q2 20171.7%
MCKESSON CORP14Q3 202214.6%
ANTHEM INC12Q4 201714.3%
TRIPLE-S MGMT CORP12Q4 20168.7%
LIFEPOINT HOSPITALS INC11Q2 201613.3%
SUPERNUS PHARMACEUTICALS INC10Q3 202115.5%
ANIKA THERAPEUTICS INC10Q4 201713.0%

View HealthInvest Partners AB's complete holdings history.

Latest significant ownerships (13-D/G)
HealthInvest Partners AB Q3 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
NOVAMED INCMarch 03, 2011405,8755.1%
THERAGENICS CORPFebruary 11, 20093,322,8469.9%
BIO IMAGING TECHNOLOGIES INCJanuary 09, 2009766,4255.3%
ALLION HEALTHCARE INCJuly 07, 2008887,2554.6%
SONIC INNOVATIONS INCJune 26, 20081,328,2014.9%
CANDELA CORP /DE/June 06, 2008697,1643.1%
INTEGRAMED AMERICA INCJune 02, 20082,2000.0%
AFP IMAGING CORPFebruary 04, 200827,5200.2%
OPHTHALMIC IMAGING SYSTEMSDecember 28, 2007834,4404.9%
ANGEION CORP/MNOctober 16, 2007196,0244.8%

View HealthInvest Partners AB's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-04-25
13F-HR2024-01-30
13F-HR2023-02-14
13F-HR2022-10-21
13F-HR2022-07-08
13F-HR2022-05-05
13F-HR2022-01-18
13F-HR2021-11-08
13F-HR2021-08-10
13F-HR2021-04-30

View HealthInvest Partners AB's complete filings history.

Compare quarters

Export HealthInvest Partners AB's holdings